The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.| STAT
Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy| STAT
CVS Caremark, one of the largest pharmacy benefit managers in the country, agreed to pay at least $45 million to the state of Illinois to settle| STAT